- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
NKI-AvL가 후원하는 임상 시험
총 16502 건
-
Al-Azhar University알려지지 않은
-
Al-Azhar University완전한
-
Al-Azhar University알려지지 않은
-
Al-Azhar University완전한
-
All India Institute of Medical Sciences, Bhubaneswar아직 모집하지 않음
-
All India Institute of Medical Sciences, Bhubaneswar모병
-
Institut du Cancer de Montpellier - Val d'Aurelle아직 모집하지 않음
-
All India Institute of Medical Sciences, Bhubaneswar아직 모집하지 않음
-
All India Institute of Medical Sciences, Bhubaneswar아직 모집하지 않음
-
All India Institute of Medical Sciences, Bhubaneswar모병
-
All India Institute of Medical Sciences, Bhubaneswar아직 모집하지 않음이 시험의 목표는 혈청 글루타티온 수치의 변화 측면에서 리스페리돈과 아리피프라졸의 효과를 비교하는 것입니다.
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
All India Institute of Medical Sciences, Bhubaneswar모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Institut du Cancer de Montpellier - Val d'Aurelle모병
-
Handok Inc.ABL Bio, Inc.; Compass Therapeutics모집하지 않고 적극적으로
-
All India Institute of Medical Sciences, Bhubaneswar완전한
-
Institut du Cancer de Montpellier - Val d'Aurelle모집하지 않고 적극적으로
-
RVL Pharmaceuticals, Inc.Osmotica Pharmaceutical US LLC완전한
-
RVL Pharmaceuticals, Inc.Osmotica Pharmaceutical US LLC빼는
-
All India Institute of Medical Sciences, Bhubaneswar완전한
-
All India Institute of Medical Sciences, Bhubaneswar완전한
-
Institut du Cancer de Montpellier - Val d'Aurelle모집하지 않고 적극적으로
-
Institut du Cancer de Montpellier - Val d'Aurelle완전한
-
Institut du Cancer de Montpellier - Val d'Aurelle완전한
-
Policlinico Casilino ASL RMBIRCCS San Raffaele알려지지 않은
-
Institut du Cancer de Montpellier - Val d'Aurelle알려지지 않은
-
Institut du Cancer de Montpellier - Val d'Aurelle완전한